Show simple item record

dc.contributor.authorVarela, Luis
dc.contributor.authorVázquez, María J.
dc.contributor.authorCordido, Fernando
dc.contributor.authorNogueiras, Rubén
dc.contributor.authorVidal-Puig, Antonio
dc.contributor.authorDiéguez, Carlos
dc.contributor.authorLópez, Miguel
dc.date.accessioned2017-04-07T08:00:42Z
dc.date.available2017-04-07T08:00:42Z
dc.date.issued2011-04-01
dc.identifier.citationVarela L, Vázquez MJ, Cordido F, Nogueiras R, Vidal-Puig A, Diéguez C, López M. Ghrelin and lipid metabolism: key partners in energy balance. J Mol Endocrinol. 2011 Feb 15;46(2):R43-63.es_ES
dc.identifier.issn0952-5041
dc.identifier.issn1479-6813
dc.identifier.urihttp://hdl.handle.net/2183/18390
dc.descriptionDisclaimer: this is not the definitive version of record of this article. This manuscript has been accepted for publication in "Journal of Molecular Endocrinology", but the version presented here has not yet been copy-edited, formatted or proofed. Consequently, Bioscientifica acepts no responsability for any errors on omissions it may contain. The definitive version is now freely avaliable at doi 10.1677/JME-10-0068
dc.description.abstract[Abstract] Ghrelin, the endogenous ligand of the GH secretagogue receptor, has a pleiotropic role in the modulation of energy balance. Recent evidence has demonstrated that besides its orexigenic role, ghrelin regulates central and peripheral lipid metabolism through specific control of hypothalamic AMP-activated protein kinase (AMPK), a critical metabolic gauge regulating both cellular and whole-body energy homeostasis. In this review, we summarize the new milestones of ghrelin's actions on energy balance, with particular focus on its molecular interaction with hypothalamic AMPK and fatty acid metabolism. Understanding this new metabolic pathway can provide new therapeutic targets for the treatment of obesity and the metabolic syndrome.es_ES
dc.description.sponsorshipEuropean Commission; FP7/2007–2013 no. 245009es_ES
dc.description.sponsorshipEuropean Commission; FP7/2007–2013; nº 018734es_ES
dc.description.sponsorshipXunta de Gailcia; PS07/12es_ES
dc.description.sponsorshipXunta de Gailcia; PGIDIT06PXIB208063PRes_ES
dc.description.sponsorshipXunta de Gailcia; 10PXIB208164PRes_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PI051024es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PI070413es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MICINN/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/PS09%2F01880/ES/ACCIONES DE LAS OREXINAS Y LA HORMONA CONCENTRADORA DE MELANINA SOBRE EL METABOLISMO LIPIDICO Y DE LA GLUCOSA, UN NUEVO MECANISMO NEUROENDOCRINO DE REGULACION DEL BALANCE ENERGETICOes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MICINN/Programa Nacional de Contratación e Incorporación/RYC-2008-02219/ESes_ES
dc.description.sponsorshipEspaña. Ministerio de Educacion y Ciencia; BFU2008es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MEC/RYC-2007-00211/ES/es_ES
dc.language.isoenges_ES
dc.publisherBioscientifica para Society for Endocrinoloogyes_ES
dc.relation.urihttp://dx.doi.org/10.1677/JME-10-0068es_ES
dc.titleGhrelin and lipid metabolism: key partners in energy balancees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
UDC.journalTitleJournal of Molecular Endocrinologyes_ES
UDC.volume46es_ES
UDC.startPageR43es_ES
UDC.endPageR63es_ES
UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.grupoInvGrupo Fisiopatoloxía Endócrina, Nutricional e Médica (FENM)es_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record